See the DrugPatentWatch profile for ruxolitinib

Ruxolitinib is a medication used to treat certain types of blood cell disorders, such as myelofibrosis and polycythemia vera. It is available under various brand names, including Jakafi and Jakavi.

In terms of dosing frequency, both Jakafi and Jakavi are typically taken orally twice daily, with or without food [1]. However, it is important to note that the specific dosage and administration instructions may vary depending on the individual patient's condition, overall health, and response to treatment.

It is also worth mentioning that there are generic versions of ruxolitinib available on the market, which may have different dosing instructions. It is essential to follow the dosage regimen prescribed by a healthcare professional.

In summary, both Jakafi and Jakavi are typically taken twice daily, but the specific dosage and administration instructions may vary depending on individual factors. Generic versions of ruxolitinib may also have different dosing instructions.

Sources:

1. DrugPatentWatch.com. (n.d.). Ruxolitinib. Retrieved from <https://www.drugpatentwatch.com/drugs/ruxolitinib>